title: The management of severe hypertension.
abstract: Although definitions of severe hypertension vary, thresholds of >or=160-170 mm Hg systolic and/or >or=110 mm Hg diastolic are in most common usage. A recent focus has been placed on systolic hypertension given the increased pulse pressure in these women. In pregnancy, there is a general consensus that severe hypertension should be treated. Among woman with pre-eclampsia, attention must be paid to other end organ dysfunction, as blood pressure (BP) management is but one aspect of care. The urgency of antihypertensive therapy will depend primarily on the absolute level of BP. However, most clinicians will also consider both the rate of BP rise and the presence of maternal symptoms. Most commonly, severe hypertension is treated with parenteral labetalol or hydralazine, or oral nifedipine (capsules or PA tablet). Other options will depend on local availability. MgSO(4) should not be relied on as an antihypertensive.
authors.affiliation: Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Lmagee@cw.bc.ca
authors.forename: Laura A
authors.initials: LA
authors.lastname: Magee
authors.forename: Peter
authors.initials: P
authors.lastname: von Dadelszen
mesh_terms: D000959:Antihypertensive Agents / Q000008:administration & dosage*; D005260:Female; D006340:Heart Rate, Fetal / Q000502:physiology; D006801:Humans; D046110:Hypertension, Pregnancy-Induced / Q000188:drug therapy* / Q000503:physiopathology*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy* / Q000503:physiopathology*
chemical_list: D000959:Antihypertensive Agents